Dr. Jitka Palich Fučíková, a scientist from the Institute of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, in collaboration with the Sotio Biotechnology Company, demonstrated that the presence of the protein calreticulin significantly influences the activation of the anti-tummor immune response and improves the prognosis of patients with lung carcinoma. She received the Česká Hlava in the Invention category (Kapsch Prize); a gala celebration was held at the University of Economics in Prague on 25 November 2018.
Photographs: Česká hlava
Reportáž na webu UK a v časopisu Forum (in Czech)
